✦ LIBER ✦

Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study)

✍ Scribed by C. Wurnig; R. Windhager; E. Schwameis; R. Kotz; A. Zoubek; F. Stockenhuber; R. W. Kurz

Book ID: 114440148
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 541 KB
Volume: 36
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1996.36296181929.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aprepitant triple therapy for the preven

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

✍ Hu, Zhihuang; Cheng, Ying; Zhang, Hongyu; Zhou, Caicun; Han, Baohui; Zhang, Yipi 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 347 KB

Can treatment with Cocculine improve the

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

✍ David Pérol, Jocelyne Provençal, Anne-claire Hardy-Bessard, David Coeffic… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 199 KB

Randomized Phase III Trial Exploring the

Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial

✍ Hoff, P. M.; Saragiotto, D. F.; Barrios, C. H.; del Giglio, A.; Coutinho, A. K.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 199 KB

The efficacy and safety of palonosetron

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

✍ Zhaocai Yu; Wenchao Liu; Ling Wang; Houjie Liang; Ying Huang; Xiaoming Si; Helon 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 91 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, phase III study of the human anti-tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate

✍ KIM, Ho-Youn ;LEE, Soo-Kon ;SONG, Yeong Wook ;YOO, Dae-Hyun ;KOH, Eun-Mi ;YOO, B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

✍ Albany, C.; Brames, M. J.; Fausel, C.; Johnson, C. S.; Picus, J.; Einhorn, L. H. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB